HISS-dependent control of insulin sensitivity in health and disease

It has been previously demonstrated that the hepatic parasympathetic nerves have a permissive role regulating the ability of insulin to release a hepatic insulin sensitizing substance (HISS) from the liver (Xie et al. 1993; Me and Lautt 1995a, 1995b). This thesis work demonstrates the involvement of...

Full description

Bibliographic Details
Main Author: Sadri, Parissa
Language:en_US
Published: 2007
Online Access:http://hdl.handle.net/1993/1990
id ndltd-LACETR-oai-collectionscanada.gc.ca-MWU.1993-1990
record_format oai_dc
spelling ndltd-LACETR-oai-collectionscanada.gc.ca-MWU.1993-19902014-03-29T03:41:44Z HISS-dependent control of insulin sensitivity in health and disease Sadri, Parissa It has been previously demonstrated that the hepatic parasympathetic nerves have a permissive role regulating the ability of insulin to release a hepatic insulin sensitizing substance (HISS) from the liver (Xie et al. 1993; Me and Lautt 1995a, 1995b). This thesis work demonstrates the involvement of other permissive factors in the release of HISS from the liver in response to insulin in health and a pathological condition in rats. Furthermore, the glucose disposal effect of insulin and insulin-like growth factor-1 (IGF-1) were compared in health and a pathological condition. To measure insulin sensitivity, we have developed a new rapid insulin sensitivity test (RIST). The RIST is a reproducible test and requires a bolus infusion of insulin (50 mU/kg) over 5 minutes. The amount of glucose infused during the RIST to maintain euglycemia is referred to as the RIST index. The release of HISS was shown to be dependent on the production of nitric oxide (NO) and prostaglandins (PGs) in the liver. Intraportal, but not intravenous, administration of a NO synthase (NOS) antagonist and a cyclooxygenase antagonist produced significant HISS-dependent insulin resistance (HDIR). Administration of a NO donor after NOS antagonism or hepatic parasympathetic denervation reversed HDIR and restored insulin sensitivity. IGF-1 (200 [mu]g/kg) had a similar glucose disposal effect to insulin (50 mU/kg) but its effect did not involve the release of HISS from the liver. In an experimental model of fetal alcohol exposure (FAE), male rats were prenatally exposed to ethanol through the maternal water supply containing 0%, 5%, 10%, 15% and 20% ethanol and female rats were prenatally exposed to 0%, 15% and 20% ethanol. FAE caused a dose-dependent increase in HDIR in both males and females in young adulthood. However, FAE did not affect the IGF-1 sensitivity. In conclusion, the permissive role of the hepatic parasympathetic nerves to the action of insulin to release HISS from the liver is through NO and PGs production in the liver. The glucose disposal effect of IGF-1 does not involve the release of HISS from the liver. FAE causes dose-dependent HDIR in young adulthood but does not alter the glucose disposal effect of IGF-1. 2007-05-22T15:12:10Z 2007-05-22T15:12:10Z 2001-01-01T00:00:00Z http://hdl.handle.net/1993/1990 en_US
collection NDLTD
language en_US
sources NDLTD
description It has been previously demonstrated that the hepatic parasympathetic nerves have a permissive role regulating the ability of insulin to release a hepatic insulin sensitizing substance (HISS) from the liver (Xie et al. 1993; Me and Lautt 1995a, 1995b). This thesis work demonstrates the involvement of other permissive factors in the release of HISS from the liver in response to insulin in health and a pathological condition in rats. Furthermore, the glucose disposal effect of insulin and insulin-like growth factor-1 (IGF-1) were compared in health and a pathological condition. To measure insulin sensitivity, we have developed a new rapid insulin sensitivity test (RIST). The RIST is a reproducible test and requires a bolus infusion of insulin (50 mU/kg) over 5 minutes. The amount of glucose infused during the RIST to maintain euglycemia is referred to as the RIST index. The release of HISS was shown to be dependent on the production of nitric oxide (NO) and prostaglandins (PGs) in the liver. Intraportal, but not intravenous, administration of a NO synthase (NOS) antagonist and a cyclooxygenase antagonist produced significant HISS-dependent insulin resistance (HDIR). Administration of a NO donor after NOS antagonism or hepatic parasympathetic denervation reversed HDIR and restored insulin sensitivity. IGF-1 (200 [mu]g/kg) had a similar glucose disposal effect to insulin (50 mU/kg) but its effect did not involve the release of HISS from the liver. In an experimental model of fetal alcohol exposure (FAE), male rats were prenatally exposed to ethanol through the maternal water supply containing 0%, 5%, 10%, 15% and 20% ethanol and female rats were prenatally exposed to 0%, 15% and 20% ethanol. FAE caused a dose-dependent increase in HDIR in both males and females in young adulthood. However, FAE did not affect the IGF-1 sensitivity. In conclusion, the permissive role of the hepatic parasympathetic nerves to the action of insulin to release HISS from the liver is through NO and PGs production in the liver. The glucose disposal effect of IGF-1 does not involve the release of HISS from the liver. FAE causes dose-dependent HDIR in young adulthood but does not alter the glucose disposal effect of IGF-1.
author Sadri, Parissa
spellingShingle Sadri, Parissa
HISS-dependent control of insulin sensitivity in health and disease
author_facet Sadri, Parissa
author_sort Sadri, Parissa
title HISS-dependent control of insulin sensitivity in health and disease
title_short HISS-dependent control of insulin sensitivity in health and disease
title_full HISS-dependent control of insulin sensitivity in health and disease
title_fullStr HISS-dependent control of insulin sensitivity in health and disease
title_full_unstemmed HISS-dependent control of insulin sensitivity in health and disease
title_sort hiss-dependent control of insulin sensitivity in health and disease
publishDate 2007
url http://hdl.handle.net/1993/1990
work_keys_str_mv AT sadriparissa hissdependentcontrolofinsulinsensitivityinhealthanddisease
_version_ 1716657594645348352